Connect
MJA
MJA

Pharmaceutical preparations

Editorials

Medications that are unaccounted for in hospitals: discrepancies in electronic records

Valentina Lichtner

Med J Aust 2022; 216 (5): 238-239

Consensus statement summary

Australian consensus recommendations for the management of hepatitis B

John S Lubel, Simone I Strasser, Alexander J Thompson, Benjamin C Cowie, Jennifer MacLachlan, Nicole L Allard, Jacinta Holmes, William W Kemp, Avik Majumdar, David Iser, Jess Howell and Gail V Matthews

Med J Aust 2022; 216 (9): 478-486

Perspectives

Does the FDA‐approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?

Andrew Gleason, Scott Ayton and Ashley I Bush

Med J Aust 2022; 216 (4): 172-174

Systematic review/meta‐analysis

Efficacy, safety, and dose‐dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta‐analysis

Christina Abdel Shaheed, Wasim Awal, Geoffrey Zhang, Stephen E Gilbert, Daniel Gallacher, Andrew McLachlan, Richard O Day, Giovanni E Ferreira, Caitlin MP Jones, Harbeer Ahedi, Mamata Tamrakar, Fiona M Blyth, Fiona Stanaway and Christopher G Maher

Med J Aust 2022; 216 (6): 305-311 Free

Medical education / Lessons from practice

COVID‐19 mRNA vaccine (Comirnaty)‐induced myocarditis

Joshua Wong, Sameer Sharma, Jessica V Yao, Anuradha Aggarwal and Leeanne Grigg

Med J Aust 2022; 216 (3): 122-123 Free

Perspectives

3D printing: potential clinical applications for personalised solid dose medications

Liam Krueger, Jared A Miles, Kathryn J Steadman, Tushar Kumeria, Christopher R Freeman and Amirali Popat

Med J Aust 2022; 216 (2): 64-67

Research

Medication not accounted for in hospital electronic medication administration records: a retrospective observational study

Kimberly Walker, Andrew M Harding, Julina Tran, Paul Wembridge, Kent Garrett, Kent MacMillan, Olivia Rofe, Nicholas Jones and David Taylor

Med J Aust 2022; 216 (5): 248-254 Free

Perspectives

What doctors should consider before prescribing e‐liquids for e‐cigarettes

Miranda P Ween, David G Chapman and Alexander N Larcombe

Med J Aust 2022; 216 (1): 14-16

Letters

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab

Ashish Srinivasan, Craig Haifer and Lena Thin

Med J Aust 2021; 215 (9): 435-435

Research

Barbiturate‐related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018

Shane Darke, Agata Chrzanowska, Gabrielle Campbell, Emma Zahra and Julia Lappin

Med J Aust 2022; 216 (4): 194-198 Free

Letters

Screening for hydroxychloroquine retinopathy in Australia

Adrian T Fung, Vicky Lu and Heather G Mack

Med J Aust 2021; 215 (9): 434-434 Free

Letters

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab

David Lim, Rhiannon Bandiera and Elizabeth Handsley

Med J Aust 2021; 215 (9): 435-435

Medical education / Lessons from practice

An unusual case of non‐infective endocarditis in undiagnosed antiphospholipid syndrome

Jessica V Yao, Subodh B Joshi, John G Morgan and Melissa GY Lee

Med J Aust 2021; 215 (7): 311-312.e1

Perspectives

Placebos in clinical care: a suggestion beyond the evidence

Christopher G Maher, Adrian C Traeger, Christina Abdel Shaheed and Mary O'Keeffe

Med J Aust 2021; 215 (6): 252-253.e1 Free

Perspectives

Effectiveness of COVID‐19 vaccines: findings from real world studies

David A Henry, Mark A Jones, Paulina Stehlik and Paul P Glasziou

Med J Aust 2021; 215 (4): 149-151.e1 Free

Research letters

Background rates of hospital transfer and death in Australian aged care facilities: estimates to assist interpretation of rates after COVID‐19 vaccination

Hazel J Clothier, Yonatan M Mesfin, Steven Strange and Jim P Buttery

Med J Aust 2021; 215 (4): 180-181 Free

Narrative review

Co‐occurring depression and insomnia in Australian primary care: recent scientific evidence

Alexander Sweetman, Leon Lack, Emer Van Ryswyk, Andrew Vakulin, Richard L Reed, Malcolm W Battersby, Nicole Lovato and Robert J Adams

Med J Aust 2021; 215 (5): 230-236

Editorials

Opioid prescribing in Australia: too much and not enough

Adrian J Dunlop, Buddhima Lokuge and Nicholas Lintzeris

Med J Aust 2021; 215 (3): 117-118 Free

Research

Psychotropic medicine prescribing and polypharmacy for people with dementia entering residential aged care: the influence of changing general practitioners

Heidi J Welberry, Louisa R Jorm, Andrea L Schaffer, Sebastiano Barbieri, Benjumin Hsu, Mark F Harris, John Hall and Henry Brodaty

Med J Aust 2021; 215 (3): 130-136 Free

Research letter

Opioid medication prescribing in Queensland, 1997‒2018: a population study

Adeleke D Adewumi, Joemer C. Maravilla, Rosa Alati, Samantha A Hollingworth, Xuelei Hu, Bill Loveday and Jason Connor

Med J Aust 2021; 215 (3): 137-138 Free

Perspectives

When will opioid agonist therapy become a normal part of comprehensive health care?

Pallavi Prathivadi and Elizabeth A Sturgiss

Med J Aust 2021; 214 (11): 504-505.e1

Letters

Buprenorphine: extended‐release formulations “a game changer”!

Katerina Lagios

Med J Aust 2021; 214 (11): 534-534.e1

Editorials

Lack of efficacy of cannabidiol for relieving back pain: time to re‐set expectations?

Chris Hayes and Jennifer H Martin

Med J Aust 2021; 214 (8): 360-361

Research letters

Increased dispensing of prescription medications in Australia early in the COVID‐19 pandemic

Mustafa Mian, Subhashaan Sreedharan and Sarah Giles

Med J Aust 2021; 214 (9): 428-429 Free

Research letters

Opioid cessation is associated with reduced pain and improved function in people attending specialist chronic pain services

Hilarie Tardif, Christopher Hayes and Samuel F Allingham

Med J Aust 2021; 214 (9): 430-432 Free